94 related articles for article (PubMed ID: 1485585)
1. [Treatment of advanced renal cell carcinoma with interferon alpha and OK-432 (streptococcal preparation)].
Shinoda M; Naide Y
Hinyokika Kiyo; 1992 Nov; 38(11):1299-304. PubMed ID: 1485585
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy with interferon-alpha and continuous infusion of 5-fluorouracil for advanced renal cell carcinoma].
Noguchi S; Shuin T; Kubota Y; Masuda M; Yao M; Hosaka M
Hinyokika Kiyo; 1995 Jul; 41(7):517-20. PubMed ID: 7668181
[TBL] [Abstract][Full Text] [Related]
5. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
[TBL] [Abstract][Full Text] [Related]
6. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
[TBL] [Abstract][Full Text] [Related]
9. [A case of complete resolution of multiple metastases of advanced renal cell carcinoma following partial jejunotomy in intestinal metastases and interferon therapy].
Miyata M; Watabe Y; Okamura K; Fujisawa M; Arima S; Yachiku S
Hinyokika Kiyo; 1988 Oct; 34(10):1783-8. PubMed ID: 3245527
[TBL] [Abstract][Full Text] [Related]
10. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
11. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
Gross AJ; Dieckmann KP; Krain J; Huland H
Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
[TBL] [Abstract][Full Text] [Related]
13. [Three cases of lung metastases of renal cell carcinoma treated with a combination of interferon-alpha, 5-fluorouracil and leucovorin].
Togashi M; Tabata T; Hirakawa K; Ohashi N; Sindoh J; Hirano T; Demura T
Hinyokika Kiyo; 1996 Jan; 42(1):43-5. PubMed ID: 8686582
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?
Huland E; Heinzer H; Huland H
Hepatogastroenterology; 1999 May; 46 Suppl 1():1257-62. PubMed ID: 10429971
[TBL] [Abstract][Full Text] [Related]
15. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Niijima T; Akaza H; Koyanagi T; Togashi M; Kumamoto Y; Funyu T; Suzuki T; Orikasa S; Yoshikawa K; Koiso K
Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinoma.
Merimsky O; Inbar M; Merimsky E; Kovner F; Spitzer E; Laufer R; Braf Z; Chaitchik S
Mol Biother; 1990 Sep; 2(3):155-9. PubMed ID: 2222899
[TBL] [Abstract][Full Text] [Related]
19. [Management of advanced renal cell carcinoma: surgical treatment of metastasis].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1994 Oct; 40(10):919-24. PubMed ID: 7992709
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
